Note: Ingredients listed on restricted chemical lists
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
General Information
Revision date
2010-10-06
Product name
THIMET 20-G SOIL AND SYSTEMIC
Chemical name
(Active Ingredient) O,O-Diethyl-S- [(ethylthio)methyl]phosphorodithioate SYNONYMS (for active ingredient): Phorate; Thimet
1.2.1 Relevant identified uses
Organophosphorus pesticide
Manufacturer Name
AMVAC CHEMICAL CORPORATION
Emergency telephone
323-264-3910
Icons in SDS
Company Information
company name
AMVAC CHEMICAL CORPORATION
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW: DANGER! POISON! Poisonous if swallowed, inhaled or absorbed through skin. Rapidly absorbed through the skin. Inhalation or skin contact may, without symptoms, progressively increase susceptibility to PHORATE (Thimet®) poisoning. Do not swallow or get in eyes, on skin or on clothing. Do not breathe vapors. Keep out of reach of children! Do not contaminate food or feed products. Toxic to fish, birds and other wildlife. Do not contaminate bodies of water.
Principle Routes of Exposure
Poisonous if swallowed, inhaled or absorbed through skin. Rapidly absorbed through skin. Inhalation or skin contact may, without symptoms, progressively increase susceptibility to Phorate poisoning. SIGNS OF ACUTE OVEREXPOSURE: Symptoms include weakness, headache, tightness in chest, blurred vision, non-reactive pinpoint pupils, salivation, sweating, nausea, vomiting, diarrhea, and abdominal cramps. In extreme cases unconsciousness, convulsions, severe respiratory depression and death may occur. SIGNS OF CHRONIC OVEREXPOSURE: Repeated exposures to small doses of Phorate (Thimet®) and other organophosphates may lower the cholinesterase to levels where the above symptoms of acute overexposure are observed. OTHER POTENTIAL HEALTH EFFECTS: Laboratory studies have shown no carcinogenic and reproductive effects in laboratory animals.
Medical Conditions Generally Aggravated by Exposure
Preexisting skin or respiratory disorders may be aggravated by exposure to components of this product. Preexisting conditions which lower cholinesterase levels increase vulnerability to cholinesterase depression. These include: (for plasma) chronic alcoholism; malnutrition; dermatomyositis; existing toxicity from exposure to carbon disulfide; benzalkonium salts, organic mercury compounds, ciguatoxins or solanines; and (for RBC) hemolytic anemia. CARE MUST BE TAKEN WHEN HANDLING PHORATE AND ITS FORMULATIONS.